Mar 09, 2023 / 09:30PM GMT
Operator
Greetings. My name is Joe, and I'll be your conference operator today. Welcome to Gritstone Bio's Fourth Quarter and Full Year 2022 Results Conference Call. Please note, this event is being recorded.
At this time, I'd like to introduce George MacDougall, Director, Investor Relations and Corporate Communications at Gritstone. Please go ahead, sir.
George MacDougall -
Thank you, operator, and thank you, everyone, for joining us from Gritstone Bio's conference call to discuss our financial results, clinical and business updates for the fourth quarter and full year 2022. With me on the call today from Gritstone Bio are Andrew Allen, Co-Founder, President and CEO; and Celia Economides, Executive Vice President and Chief Financial Officer. Joining us for the Q&A portion will be Karin Jooss, our Head of R&D. Today, after the market closed, we issued a press release providing our fourth quarter 2022 and full year 2022 financial results as well as clinical and business updates. The press release is available on our website. I'd like to remind you that today's
Q4 2022 Gritstone bio Inc Earnings Call Transcript
Mar 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers